Dongsung Pharm - Asset Resilience Ratio
Dongsung Pharm (002210) has an Asset Resilience Ratio of 0.00% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Dongsung Pharm (002210) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2022)
This chart shows how Dongsung Pharm's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Dongsung Pharm to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Dongsung Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Dongsung Pharm market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩-1.00K | -0.0% |
| Total Liquid Assets | ₩-1.00K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Dongsung Pharm maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Dongsung Pharm Industry Peers by Asset Resilience Ratio
Compare Dongsung Pharm's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
SIMCERE PHARMAC. GRP LTD
F:S2P |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
Annual Asset Resilience Ratio for Dongsung Pharm (2008–2022)
The table below shows the annual Asset Resilience Ratio data for Dongsung Pharm.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.00% | ₩-300.00 ≈ $-0.20 |
₩107.70 Billion ≈ $72.99 Million |
-1.91pp |
| 2021-12-31 | 1.91% | ₩2.00 Billion ≈ $1.36 Million |
₩104.58 Billion ≈ $70.87 Million |
-5.30pp |
| 2020-12-31 | 7.22% | ₩9.07 Billion ≈ $6.15 Million |
₩125.72 Billion ≈ $85.20 Million |
-6.89pp |
| 2019-12-31 | 14.10% | ₩18.58 Billion ≈ $12.59 Million |
₩131.73 Billion ≈ $89.27 Million |
-7.31pp |
| 2018-12-31 | 21.41% | ₩30.02 Billion ≈ $20.34 Million |
₩140.20 Billion ≈ $95.01 Million |
+10.23pp |
| 2017-12-31 | 11.18% | ₩13.88 Billion ≈ $9.41 Million |
₩124.18 Billion ≈ $84.16 Million |
-2.59pp |
| 2016-12-31 | 13.76% | ₩17.26 Billion ≈ $11.70 Million |
₩125.39 Billion ≈ $84.97 Million |
+13.14pp |
| 2011-12-31 | 0.62% | ₩774.12 Million ≈ $524.61K |
₩124.58 Billion ≈ $84.42 Million |
-1.17pp |
| 2010-12-31 | 1.79% | ₩2.29 Billion ≈ $1.55 Million |
₩127.81 Billion ≈ $86.61 Million |
-1.96pp |
| 2009-12-31 | 3.75% | ₩4.79 Billion ≈ $3.25 Million |
₩127.91 Billion ≈ $86.68 Million |
+3.42pp |
| 2008-12-31 | 0.33% | ₩405.00 Million ≈ $274.46K |
₩124.57 Billion ≈ $84.42 Million |
-- |
About Dongsung Pharm
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-… Read more